Area of research
Epidemiology · Hepatology
Research interest
Research interests include Medicine, Internal medicine, Entecavir, Traditional Chinese medicine, Modalities, and Physical medicine and rehabilitation.
Comparative efficacy and safety of exercise modalities in knee osteoarthritis: systematic review and network meta-analysis
Risk-stratified lifetime risk and incidence of hip fracture and falls in middle-aged and elderly Chinese population: The China health and retirement longitudinal study
3D Mechanical Response Stem Cell Complex Repairs Spinal Cord Injury by Promoting Neurogenesis and Regulating Tissue Homeostasis
The impact of patellofemoral joint diseases on functional outcomes and prosthesis survival in patients undergoing unicompartmental knee arthroplasty: a systematic review and meta-analysis
3D bioprinting approaches for spinal cord injury repair
Exosomes derived from 3D-cultured MSCs alleviate knee osteoarthritis by promoting M2 macrophage polarization through miR-365a-5p and inhibiting TLR2/Myd88/NF-κB pathway
Ellagic acid improves osteoarthritis by inhibiting <scp>PGE2</scp> production in <scp>M1</scp> macrophages via targeting <scp>PTGS2</scp>
Tissue-engineered mesenchymal stem cell constructs alleviate tendinopathy by suppressing vascularization
Regression-based Chinese norms of number connection test A and digit symbol test for diagnosing minimal hepatic encephalopathy
The prevalence of hip osteoarthritis: a systematic review and meta-analysis
Failure modes after anterior cruciate ligament reconstruction: a systematic review and meta-analysis
MicroRNA expression in osteoarthritis: a meta-analysis
Biomaterials for Tissue-Engineered Treatment of Tendinopathy in Animal Models: A Systematic Review
Preclinical Studies and Clinical Trials on Cell-Based Treatments for Meniscus Regeneration
The silencing of NREP aggravates OA cartilage damage through the TGF-β1/Smad2/3 pathway in chondrocytes
Entecavir combining Chinese herbal medicine for HBeAg-positive chronic hepatitis B patients: a randomized, controlled trial
Adefovir Dipivoxil plus Chinese Medicine in HBeAg-Positive Chronic Hepatitis B Patients: A Randomized Controlled 48-Week Trial
Chinese herbal medicine combined with entecavir to reduce the off-therapy recurrence risk in HBeAg-positive chronic hepatitis B patients: a multi-center, double-blind, randomized controlled trial in China
Chinese Herbal Medicine Combined with Entecavir for HBeAg Positive Chronic Hepatitis B: Study Protocol for a Multi-Center, Double-Blind Randomized-Controlled Trial